Search Results - "Yan, Phyllis"

Refine Results
  1. 1

    Alpha blockers for treatment of ureteric stones: systematic review and meta-analysis by Hollingsworth, John M, Canales, Benjamin K, Rogers, Mary A M, Sukumar, Shyam, Yan, Phyllis, Kuntz, Gretchen M, Dahm, Philipp

    Published in BMJ (Online) (01-12-2016)
    “…Objective To investigate the efficacy and safety of alpha blockers in the treatment of patients with ureteric stones.Design Systematic review and…”
    Get full text
    Journal Article
  2. 2

    Performance in the Medicare Shared Savings Program After Accounting for Nonrandom Exit: An Instrumental Variable Analysis by Markovitz, Adam A, Hollingsworth, John M, Ayanian, John Z, Norton, Edward C, Yan, Phyllis L, Ryan, Andrew M

    Published in Annals of internal medicine (02-07-2019)
    “…Accountable care organizations (ACOs) in the Medicare Shared Savings Program (MSSP) are associated with modest savings. However, prior research may overstate…”
    Get full text
    Journal Article
  3. 3

    Comparison of Selective Versus Empiric Pharmacologic Preventative Therapy With Kidney Stone Recurrence by Hsi, Ryan S., Yan, Phyllis L., Goldfarb, David S., Egbuji, Ada, Si, Yajuan, Shahinian, Vahakn, Hollingsworth, John M.

    Published in Urology (Ridgewood, N.J.) (01-03-2021)
    “…To assess the effectiveness of an empiric approach to metabolic stone prevention. Using medical claims from a cohort of working age adults with kidney stone…”
    Get full text
    Journal Article
  4. 4

    Comparison of Selective vs Empiric Pharmacologic Preventive Therapy of Kidney Stone Recurrence With High-Risk Features by Hsi, Ryan S., Yan, Phyllis L., Crivelli, Joseph J., Goldfarb, David S., Shahinian, Vahakn, Hollingsworth, John M.

    Published in Urology (Ridgewood, N.J.) (01-06-2022)
    “…To compare the frequency of stone-related events among subgroups of high-risk patients with and without 24-hour urine testing before preventive pharmacological…”
    Get full text
    Journal Article
  5. 5

    Comparison of Empiric Preventative Pharmacologic Therapies on Stone Recurrence Among Patients with Kidney Stone Disease by Hsi, Ryan S., Yan, Phyllis L., Crivelli, Joseph J., Goldfarb, David S., Shahinian, Vahakn, Hollingsworth, John M.

    Published in Urology (Ridgewood, N.J.) (01-08-2022)
    “…To compare the frequency of stone-related events among patients receiving thiazides, alkali citrate, and allopurinol without prior 24 h urine testing.  It is…”
    Get full text
    Journal Article
  6. 6

    New Persistent Opioid Use After Outpatient Ureteroscopy for Upper Tract Stone Treatment by Tam, Christopher A., Dauw, Casey A., Ghani, Khurshid R., Gunaseelan, Vidhya, Kim, Tae, Leavitt, David A., Raisky, Jeremy, Yan, Phyllis L., Hollingsworth, John M.

    Published in Urology (Ridgewood, N.J.) (01-12-2019)
    “…To measure the incidence of persistent opioid use following ureteroscopy (URS). Over 100 Americans die every day from opioid overdose. Recent studies suggest…”
    Get full text
    Journal Article
  7. 7

    Risk Adjustment In Medicare ACO Program Deters Coding Increases But May Lead ACOs To Drop High-Risk Beneficiaries by Markovitz, Adam A., Hollingsworth, John M., Ayanian, John Z., Norton, Edward C., Moloci, Nicholas M., Yan, Phyllis L., Ryan, Andrew M.

    Published in Health Affairs (01-02-2019)
    “…The Medicare Shared Savings Program (MSSP) adjusts savings benchmarks by beneficiaries' baseline risk scores. To discourage increased coding intensity, the…”
    Get full text
    Journal Article
  8. 8

    Accountable Care Organizations and Spending for Patients Undergoing Long-Term Dialysis by Bakre, Shivani, Hollingsworth, John M, Yan, Phyllis L, Lawton, Emily J, Hirth, Richard A, Shahinian, Vahakn B

    “…Despite representing 1% of the population, beneficiaries on long-term dialysis account for over 7% of Medicare's fee-for-service spending. Because of their…”
    Get full text
    Journal Article
  9. 9

    Out-Of-Network Primary Care Is Associated With Higher Per Beneficiary Spending In Medicare ACOs by Lin, Sunny C, Yan, Phyllis L, Moloci, Nicholas M, Lawton, Emily J, Ryan, Andrew M, Adler-Milstein, Julia, Hollingsworth, John M

    Published in Health affairs (Millwood, Va.) (01-02-2020)
    “…Despite expectations that Medicare accountable care organizations (ACOs) would curb health care spending, their effect has been modest. One possible…”
    Get full text
    Journal Article
  10. 10

    Provider Care Team Segregation and Operative Mortality Following Coronary Artery Bypass Grafting by Hollingsworth, John M., Yu, Xianshi, Yan, Phyllis L., Yoo, Hyesun, Telem, Dana A., Yankah, Ekow N., Zhu, Ji, Waljee, Akbar K., Nallamothu, Brahmajee K.

    “…Studies have shown that Black patients die more frequently following coronary artery bypass grafting than their White counterparts for reasons not fully…”
    Get full text
    Journal Article
  11. 11

    Comparison of Class-Specific Side Effects Across Preventative Pharmacologic Therapies for Kidney Stone Disease by Hsi, Ryan S, Crivelli, Joseph J, Yan, Phyllis L, Shahinian, Vahakn, Hollingsworth, John M

    Published in Urology practice (01-01-2024)
    “…Clinical guidelines recommend monitoring for metabolic derangements while on preventive pharmacologic therapy for kidney stone disease. The study objective was…”
    Get full text
    Journal Article
  12. 12

    Complications of Delivery Among Mothers With Spina Bifida by Shepard, Courtney L., Yan, Phyllis L., Kielb, Stephanie J., Wittmann, Daniela A., Quint, Elisabeth H., Kraft, Kate H., Hollingsworth, John M.

    Published in Urology (Ridgewood, N.J.) (01-01-2019)
    “…To determine rates and types of peripartum morbidity among delivering women with spina bifida (SB) compared to those without SB. The rates of pregnancy and…”
    Get full text
    Journal Article
  13. 13

    Associations Between Provider Specialty and Use of Follow-up Testing Among Patients on Preventive Pharmacological Therapy for Urinary Stone Disease by Crivelli, Joseph J, Yan, Phyllis L, Shahinian, Vahakn, Hsi, Ryan S, Hollingsworth, John M

    Published in Urology practice (01-07-2023)
    “…The AUA Medical Management of Kidney Stones guideline outlines recommendations on follow-up testing for patients prescribed preventive pharmacological therapy…”
    Get full text
    Journal Article
  14. 14

    Thiazide Dose, Urine Calcium, and Symptomatic Kidney Stone Events by Hsi, Ryan S, Yan, Phyllis L, Maalouf, Naim M, Best, Sara L, Asplin, John R, Shahinian, Vahakn, Hollingsworth, John M

    Published in JAMA network open (01-08-2024)
    “…This cohort study examines the association between thiazide dose and urine calcium reduction and correlates urine calcium changes with the occurrence of…”
    Get full text
    Journal Article
  15. 15

    Pregnancy among mothers with spina bifida by Shepard, Courtney L., Yan, Phyllis L., Hollingsworth, John M., Kraft, Kate H.

    Published in Journal of pediatric urology (01-02-2018)
    “…Recognizing the importance of sexual and reproductive health to patients with spina bifida (SB), pediatric urologists have taken responsibility for initiating…”
    Get full text
    Journal Article
  16. 16

    Emergency Department Switching and Duplicate Computed Tomography Scans in Patients With Kidney Stones by Shah, Parth K., Yan, Phyllis L., Dauw, Casey A., Hollenbeck, Brent K., Ghani, Khurshid R., Luckenbaugh, Amy N., Hollingsworth, John M.

    Published in Urology (Ridgewood, N.J.) (01-04-2018)
    “…To test whether duplicate imaging relates to a lack of information sharing among providers, we measured the association between emergency department (ED)…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19
  20. 20